Member-only story

Biotechnology may become an outdated approach

Ihor Kendiukhov
6 min readJan 20, 2020

--

We live in a world where biology, biotechnology, and biomedicine are experiencing a boom of unprecedented proportions, entire industries arise almost every month, and investor money flows accelerate.

The volume of bio-data, the quantity, and quality of discoveries, as well as the power of their practical applications, make modern biology, according to many researchers and analysts, the most dynamic and promising of the sciences.

Some already call the 21st century “the century of living systems.” With anticipation, we expect the time when, after cancer and Alzheimer’s disease, we will defeat death itself.

It seems that the day is approaching when the biomachine under the name “Homo Sapiens” will be completely decrypted, understood, subject to reverse engineering with its subsequent unlimited augmentation.

I myself invest a considerable amount of time in the study of modern biotechnology, participate in various projects in this field and look forward to its great future. However, sometimes I wonder whether I replace future prospects with present trends.

Since ancient times, people made a strict distinction between the world of the living and the world of the technology, often they were even considered as antipodes, but now biology becomes technology, and organisms

--

--

Ihor Kendiukhov
Ihor Kendiukhov

Written by Ihor Kendiukhov

VC, deep tech, and finance expert and analyst with an educational background in economics and biology focused on disruptive technologies and markets.

Responses (1)